3.
|
Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Completed Age: 15 and over Sponsor: NCI, Other Protocol IDs: CDR0000065328, WSU-1294, NCI-T96-0004, T96-0004, NCT00002923
|
4.
|
Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Closed Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000068666, DFCI-00102, NCI-1653, 1653, NCT00017238
|